Rigorous surveillance of children at high risk for developing myelodysplastic syndrome (MDS) is especially warranted, ...

The approval follows a heightened regulatory focus on CAR-T cell therapy safety this year. In April, the FDA mandated boxed ...

Associate Professor Tam Wai Leong, Deputy Executive Director of A*STAR Genome Institute of Singapore (A*STAR GIS), and ...

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- ...

The bottom line is that the key to better cancer outcomes is found in early detection. Most malignancies that usually affect ...

While Monday’s trading session was a win for CERo shareholders, the stock’s year-to-date (YTD) performance paints a more complex picture. As of today, CERO is down by a staggering -98.59% YTD, which ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Underscoring how trials can benefit all members of a community and discussing spirituality may improve enrollment of Black ...

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy.

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic signatures.

Like other CAR-T products, Aucatzyl still comes with an FDA boxed warning for CRS, neurotoxicity and secondary T-cell malignancies. A lack of REMS requirement could work to further support adoption by ...

Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Vor Biopharma (VOR – Research Report). The associated price ...